“Top-flight lawyers who are as good as it gets.”
Chambers USA
Principal Benjamin Gluck was featured in the article, “The Price of Pain: Indictments Allege a Massive Compound Cream Scam,” published by Southern California Radio, discussing his client in a case alleging $100 million in workers compensation insurance fraud.
Bird Marella attorney Mary Hansel will moderate and present at a panel discussion on Thursday, September 11th at 4.15 p.m. in connection with the California State Bar’s Annual Meeting.
Bird Marella attorneys Benjamin Gluck and Paul Chan will be featured speakers at CLE International’s 2nd Annual Qui Tam Conference, and will participate in the panel discussion “Ethics – Trouble Spots in FCA Litigation,” at 4:30 p.m. on Tuesday, October 28.
Attorney Gary Lincenberg was featured in a Law360 article about his successful defense of the highly esteemed former Chair of the Political Science Department at UCLA, Michael Lofchie,
Principals Gary Lincenberg and Thomas Reichert were featured in the Law360 article, “Energy Co. Loses Damages Appeal in Microcap Fraud Suit,”
The DEA increased the restrictions on prescribing hydrocodone combinations, moving them from Schedule III Narcotics to Schedule II in a change that has been in the making for some time. One of the new regulations prevents patients from simply refilling prescriptions and instead requires patients to visit their doctors again ...
Bird Marella principal Tom Freeman has been selected as a Fellow of the Litigation Counsel of America (LCA). Mr. Freeman’s practice focuses on civil litigation at the trial and appellate levels, and criminal appeals.
Principal Ronald Nessim was selected by his peers as the 2015 Los Angeles Criminal Defense: White-Collar “Lawyer of the Year” by Best Lawyers®.
Principals Terry Bird, Vincent Marella, Ronald Nessim, and Gary Lincenberg were selected by their peers for inclusion in The Best Lawyers in America© 2015 for their work in White Collar Criminal Defense.
Principal Benjamin Gluck was featured in the article, “Pharmacies Turn Drugs Into Profits, Pitting Insurers vs. Compounders,” published by The New York Times discussing the sky-high priced and increasingly prescribed compounded medicines,
